CLINICAL_TRIALS
trial_result
· 2024-12-19
Clinical Trial Update: Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR) [NA]
Summary
The individualized lung tumor stereotactic ablative radiotherapy (iSABR) trial for non-small cell lung cancer has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: Non-small Cell Lung Cancer (NSCLC) | NA | Status: COMPLETED | Results posted: 2024-12-19